Target intelligence / Profile preview

Autoinducer-2 kinase (LsrK) (LsrK)

Target
LsrK
Molecular classification
Enzyme, Kinase, FGGY carbohydrate kinase family
01

Overview

LsrK is a cytoplasmic kinase belonging to the FGGY family of carbohydrate kinases, primarily found in enteric bacteria such as Escherichia coli and Salmonella Typhimurium (UniProt: P0A9I0). It is the central enzyme in the LuxS/AI-2 quorum sensing system, responsible for phosphorylating the signaling molecule Autoinducer-2 (AI-2) to phospho-AI-2 (P-AI-2) upon its entry into the cell (PMID: 15659676). This phosphorylation event is critical because P-AI-2 acts as an inducer by binding to and inactivating the transcriptional repressor LsrR, thereby upregulating the lsr operon and promoting further AI-2 uptake and processing (PMID: 19129207). By controlling the intracellular concentration of P-AI-2, LsrK regulates diverse bacterial processes including biofilm formation, virulence factor expression, and niche adaptation (PMID: 26163278). Consequently, LsrK is considered a high-priority target for the development of pathoblockers or anti-virulence drugs that aim to disrupt bacterial communication and attenuate infection without imposing the strong selective pressure associated with traditional bactericidal antibiotics (PMID: 31441295).

Other names
AI-2 kinaseLuxS-regulated kinaseLsrKPhospho-AI-2 kinase
02

Mechanism of action

Inhibition of LsrK-mediated phosphorylation of Autoinducer-2 (AI-2), preventing the inactivation of the LsrR repressor and subsequent activation of the lsr operon, thereby disrupting quorum sensing-controlled virulence (PMID: 26163278).

03

Biological functions

Quorum sensingSignal transductionBiofilm formationBacterial communicationPhosphorylation of Autoinducer-2
04

Disease associations

Bacterial infectionAntimicrobial resistance
05

Safety considerations

Potential off-target inhibition of host FGGY kinasesAlteration of commensal gut microbiota compositionBacterial compensation via alternative signaling pathways
06

Interacting drugs

Harmane

3 more in the full profile.

07

Biomarkers

Intracellular phospho-AI-2 levelsLsr operon mRNA expressionBiofilm density

Beyond the preview

Go deeper on Autoinducer-2 kinase (LsrK) (LsrK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autoinducer-2 kinase (LsrK) (LsrK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call